EVO
Evotec SE
EVO lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
EVO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Under pressure |
EVO's revenue, profitability, cash flow and balance sheet are all currently under pressure.
EVO PE Valuation
EVO has no meaningful PE right now: it lost money over the past year.
EVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect EVO's losses to shrink, with revenue declining.
EVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.62 | -$0.14 |
| Q1 2026 | -$0.61 | +$0.03 |
| Q4 2025 | -$0.32 | +$0.29 |
| Q3 2025 | -$0.49 | +$0.05 |
| Q2 2025 | -$0.48 | +$0.06 |
| Q1 2025 | -$0.64 | -$0.35 |
| Q4 2024 | -$0.61 | -$0.35 |
| Q3 2024 | -$0.54 | -$0.24 |
EVO lost $0.62 per share over the past year, a bigger loss than the year before.
EVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $162M | -15% |
| Q1 2026 | $176.9M | -20% |
| Q4 2025 | $278.7M | +13% |
| Q3 2025 | $182.1M | -11% |
| Q2 2025 | $190.2M | -6% |
| Q1 2025 | $222.2M | -4.2% |
| Q4 2024 | $245.8M | +9.9% |
| Q3 2024 | $205.4M | -5.8% |
EVO's revenue is shrinking: $162M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -36% | -19 points |
| Q1 2026 | -35% | -25 points |
| Q4 2025 | 9.6% | +6.5 points |
| Q3 2025 | -27% | -13 points |
| Q2 2025 | -16% | +41 points |
| Q1 2025 | -10% | -1.3 points |
| Q4 2024 | 3.1% | +8.8 points |
| Q3 2024 | -14% | -8.1 points |
EVO's operating margin was −36% last quarter, down 19 points from the same quarter a year ago, near the bottom of its range since 2019.
EVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$132.8M | -4534% |
| Q1 2026 | -$7.1M | +$52.5M |
| Q4 2025 | $51.7M | -5.2% |
| Q3 2025 | -$98.8M | -724% |
| Q2 2025 | $3M | +$112.7M |
| Q1 2025 | -$59.6M | +$45.8M |
| Q4 2024 | $54.6M | +$102.8M |
| Q3 2024 | $15.8M | +$43.8M |
EVO's free cash flow was −$187M over the past year, against $14M the year before.
EVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +403K shares |
| 1 year | +0.1% | +334K shares |
| 3 years | +0.5% | +1.7M shares |
| 5 years | +8.2% | +26.9M shares |
| Available history | +19% | +56M shares |
EVO has 356M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $171,079 |
EVO hasn't bought back shares in the past year.
EVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 3.4x | Elevated |
| Q2 2024 | 89.3x | High |
| Q1 2024 | 36.0x | High |
| Q4 2023 | 8.8x | High |
| Q3 2023 | 2.6x | Moderate |
| Q2 2023 | 156.6x | High |
| Q2 2022 | -2.7x | Net Cash |
| Q1 2022 | -0.9x | Net Cash |
EVO's net debt is about 3.4 years of its operating earnings (EBITDA), up from 2.6 years a year ago.
EVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 34.1 | Neutral |
EVO's weekly RSI is 38 (neutral) and its Stochastic is 34 (neutral).
EVO PE vs Healthcare Sector
| Metric | EVO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
EVO has no meaningful PE right now: it lost money over the past year.
EVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.56 | 6.4% above |
| 20 week MA | $1.85 | 10% below |
| 50 week MA | $2.57 | 35% below |
| 100 week MA | $3.25 | 49% below |
| 200 week MA | $5.60 | 70% below |
EVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 70% below its 200-week average.
EVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $12.9 | $17.4 | +35% |
| 2021 | $17.4 | $22.6 | +30% |
| 2022 | $22.6 | $8.06 | -64% |
| 2023 | $8.06 | $11.7 | +46% |
| 2024 | $11.7 | $4.54 | -61% |
| 2025 | $4.54 | $3.11 | -31% |
| 2026 YTD | $3.11 | $1.66 | -47% |
EVO has finished lower in three of the last six years. It's down 47% so far in 2026.